ARTICLE | Strategy

A very focused $20M start-up

September 26, 1994 7:00 AM UTC

Cancer BioScience Corp., a new company designed to bridge the worlds of pure science and applied medicine, is slated to be launched in October with initial capital of about $20 million from private individuals.

The Boston-based company will combine two newly popular concepts in company development: a disease focus and a "virtual company" structure. ...